LUNA MEDICAL TECHNOLOGIES INC
8-K, 2000-05-24
IN VITRO & IN VIVO DIAGNOSTIC SUBSTANCES
Previous: TRUEVISION INTERNATIONAL INC, SB-2/A, 2000-05-24
Next: TREND MICRO INC, 20-F, 2000-05-24




                       SECURITIES AND EXCHANGE COMMISSION
                             WASHINGTON, D.C. 20549


                                    FORM 8-K

                                 CURRENT REPORT



     Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934

          Date of Report (Date of earliest event reported): May 9, 2000



<TABLE>
<S>                                  <C>                                        <C>
Nevada                                    Luna Medical Technologies, Inc.                     98-0207745
(State or other jurisdiction of      (Exact name of registrant as specified     (I.R.S. Employer Identification No.)
incorporation or organization)                  in its charter)


Suite 400, 900 West Hastings Street, Vancouver, British Columbia, Canada                       V6C 1E5
(Address of principal executive offices)                                                      (Zip Code)
</TABLE>


                                 (604) 687-0719
              (Registrant's telephone number, including area code)




                              Thomas E. Stepp, Jr.

                              Stepp & Beauchamp LLP

                           1301 Dove Street, Suite 460

                         Newport Beach, California 92660

                                 (949) 660-9700

                            Facsimile: (949) 660-9010

                                   Page 1 of 2


<PAGE>

ITEM 5.   OTHER EVENTS

     On May 9, 2000, Registrant accepted the resignation of Mr. Brad Desaulniers
as  Registrant's  President  and Chief  Operating  Officer  and as a director of
Registrant. Mr. Desaulniers' short-term management contract was not renewed, and
Mr. Desaulniers left to pursue other  opportunities.  Registrant is not aware of
any disagreements on any matter relating to operations, policies or practices.

     Mr. Gordon C.  McDougall has been appointed  President in Mr.  Desaulniers'
place, and Mr. McDougall will continue as the sole director of Registrant.


                                   SIGNATURES

     Pursuant to the  requirements of the Securities  Exchange Act of 1934, each
Registrant  has  duly  caused  this  report  to  be  signed  on  behalf  of  the
undersigned, thereunto duly authorized.



                                          Luna Medical Technologies, Inc.


DATED: May 16, 2000                       By: /s/ Gordon McDougall, President
                                             -----------------------------------
                                             Gordon McDougall, President

                                       2



© 2022 IncJournal is not affiliated with or endorsed by the U.S. Securities and Exchange Commission